Literature DB >> 22236479

Thioredoxin interacting protein genetic variation is associated with diabetes and hypertension in the Brazilian general population.

Noely E Ferreira1, Samantha Omae, Abel Pereira, Mariliza V Rodrigues, Ayumi A Miyakawa, Luciene C G Campos, Paulo C J L Santos, Luiz A Dallan, Tânia L Martinez, Raul D Santos, José G Mill, José E Krieger, Alexandre C Pereira.   

Abstract

OBJECTIVE: To investigate the relationship between TXNIP polymorphisms, diabetes and hypertension phenotypes in the Brazilian general population.
METHODS: Five hundred seventy-six individuals randomly selected from the general urban population according to the MONICA-WHO project guidelines were phenotyped for cardiovascular risk factors. A second, independent, sample composed of 487 family-trios from a different site was also selected. Nine TXNIP polymorphisms were studied. The potential association between TXNIP variability and glucose-phenotypes in children was also explored. TXNIP expression was quantified by real-time PCR in 53 samples from human smooth muscle cells primary culture.
RESULTS: TXNIP rs7211 and rs7212 polymorphisms were significantly associated with glucose and blood pressure related phenotypes. In multivariate logistic regression models the studied markers remained associated with diabetes even after adjustment for covariates. TXNIP rs7211 T/rs7212 G haplotype (present in approximately 17% of individuals) was significantly associated to diabetes in both samples. In children, the TXNIP rs7211 T/rs7212 G haplotype was associated with fasting insulin concentrations. Finally, cells harboring TXNIP rs7212 G allele presented higher TXNIP expression levels compared with carriers of TXNIP rs7212 CC genotype (p=0.02).
CONCLUSION: Carriers of TXNIP genetic variants presented higher TXNIP expression, early signs of glucose homeostasis derangement and increased susceptibility to chronic metabolic conditions such as diabetes and hypertension. Our data suggest that genetic variation in the TXNIP gene may act as a "common ground" modulator of both traits: diabetes and hypertension. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22236479     DOI: 10.1016/j.atherosclerosis.2011.12.009

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

1.  Novel epigenetic determinants of type 2 diabetes in Mexican-American families.

Authors:  Hemant Kulkarni; Mark Z Kos; Jennifer Neary; Thomas D Dyer; Jack W Kent; Harald H H Göring; Shelley A Cole; Anthony G Comuzzie; Laura Almasy; Michael C Mahaney; Joanne E Curran; John Blangero; Melanie A Carless
Journal:  Hum Mol Genet       Date:  2015-06-22       Impact factor: 6.150

2.  Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.

Authors:  Chang Hyun Byon; Tieyan Han; Judy Wu; Simon T Hui
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

Review 3.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

4.  Galectin-3 induces vascular smooth muscle cells calcification via AMPK/TXNIP pathway.

Authors:  Lei Tian; Yong Wang; Ruiyan Zhang
Journal:  Aging (Albany NY)       Date:  2022-06-27       Impact factor: 5.955

Review 5.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

6.  Thioredoxin-interacting protein promotes high-glucose-induced macrovascular endothelial dysfunction.

Authors:  Xiaoyu Li; Karen L Kover; Daniel P Heruth; Dara J Watkins; Yanchun Guo; Wayne V Moore; Luke G He; Mengwei Zang; Mark A Clements; Yun Yan
Journal:  Biochem Biophys Res Commun       Date:  2017-09-07       Impact factor: 3.575

7.  MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population.

Authors:  Paulo C J L Santos; Theo G M Oliveira; Pedro A Lemos; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2012-06-28       Impact factor: 3.876

8.  The Association Study between Twenty One Polymorphisms in Seven Candidate Genes and Coronary Heart Diseases in Chinese Han Population.

Authors:  Barrak F Alobeidy; Cong Li; Alya A Alzobair; Tao Liu; Junzhang Zhao; Yuan Fang; Fang Zheng
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

9.  Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21.

Authors:  Luciana Gioli-Pereira; Paulo Caleb Junior Lima Santos; Noely Evangelista Ferreira; Whady Armindo Hueb; Jose Eduardo Krieger; Alexandre Costa Pereira
Journal:  BMC Cardiovasc Disord       Date:  2012-08-02       Impact factor: 2.298

10.  LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.

Authors:  Paulo Cjl Santos; Carolina T Bueno; Pedro A Lemos; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2014-04-29       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.